Thursday, October 29, 2026
One filing from small caps that hit EDGAR on October 28, 2026, each with one factual line and a link to the source. Summaries of public SEC filings, not investment advice. Always read the filing.
Milestone Pharmaceuticals says it received a Nasdaq notice on October 23, 2026 that it does not meet the $1.00 minimum bid price requirement; it has a period of 180 calendar days, or until April 21, 2027, to regain compliance.
Read the filing on sec.gov →Today's full issue flagged 15 filings: auditor changes, restatements, delisting notices, bankruptcies and going-concern language, each linked to EDGAR. It's free, one email each weekday.
Unsubscribe anytime in one click. Not investment advice. See a sample issue →